株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界における医薬品と医療機器のコンビネーション製品市場:2017-2027年

Global Drug-Device Combination Market 2017-2027: Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches

発行 Visiongain Ltd 商品コード 562115
出版日 ページ情報 英文 151 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=149.86円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
世界における医薬品と医療機器のコンビネーション製品市場:2017-2027年 Global Drug-Device Combination Market 2017-2027: Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches
出版日: 2017年08月30日 ページ情報: 英文 151 Pages
概要

世界におけるコンビネーション製品 (医薬品と医療機器を組み合わせた製品) の市場規模は2016年に1370億米ドルとなりましたが、予測期間の前半は6.2%のCAGR (年間複合成長率) で成長すると予測されています。2016年において、経粘膜的製品セグメントは21%のシェアを占め、同市場の大半を構成しました。

当レポートでは、世界のコンビネーション製品市場について調査分析し、市場の概要、エンドユーザー・製品・地域別の市場予測、主要地域市場の分析、市場影響要因の分析、および主要企業のプロファイルなどを提供しています。

第1章 調査概要

第2章 医薬品-医療機器コンビネーション製品市場の定義

  • 医薬品-医療機器コンビネーション製品とは?
  • 医薬品-医療機器コンビネーション製品の種類
    • 薬剤溶出ステント (DES)
    • 光増感剤
    • 整形外科製品
    • 輸液ポンプ
    • 創傷ケア製品
    • 経粘膜的製品
    • 経皮的製品
  • 医薬品-医療機器コンビネーション製品市場構造
  • 医薬品-医療機器コンビネーション製品市場の分類

第3章 医薬品-医療機器コンビネーション製品の世界市場:エンドユーザー別

  • 病院・診療所市場の予測・分析
  • 救急救命センター市場の予測・分析
  • 外来外科センター市場の予測・分析
  • 在宅医療市場の予測・分析

第4章 医薬品-医療機器コンビネーション製品の世界市場:製品別

  • 薬剤溶出ステント (DES) 市場の予測・分析
  • 光増感剤市場の予測・分析
  • 整形外科製品市場の予測・分析
  • 輸液ポンプ市場の予測・分析
  • 創傷ケア市場の予測・分析
  • 経粘膜的製品市場の予測・分析
  • 経皮的製品市場の予測・分析
  • その他市場の予測・分析

第5章 地域の医薬品-医療機器コンビネーション製品市場予測

  • 地域の医薬品-医療機器コンビネーション製品市場予測
  • 北米の医薬品-医療機器コンビネーション製品市場予測
  • 北米の医薬品-医療機器コンビネーション製品市場予測:製品別
  • 北米の医薬品-医療機器コンビネーション製品市場予測:エンドユーザー別
  • 欧州の医薬品-医療機器コンビネーション製品市場予測
  • 欧州の医薬品-医療機器コンビネーション製品市場予測:製品別
  • 欧州の医薬品-医療機器コンビネーション製品市場予測:エンドユーザー別
  • アジア太平洋の医薬品-医療機器コンビネーション製品市場予測
  • アジア太平洋の医薬品-医療機器コンビネーション製品市場予測:製品別
  • 医薬品-医療機器コンビネーション製品市場予測:エンドユーザー別
  • その他 (RoW) の医薬品-医療機器コンビネーション製品市場予測

第6章 促進因子・抑制因子

  • 促進因子・抑制因子
  • 促進因子
  • 抑制因子

第7章 医薬品-医療機器コンビネーション製品市場における主要企業

  • Medtronic
  • Boston Scientific Corporation
  • Stryker Corporation
  • Ethicon Inc.
  • C. R. Bard Inc.
  • Medline Industries Inc.
  • Mylan Inc.
  • テルモ
  • Pinnacle Biologics Inc.
  • W.L. Gore & Associates Inc.

第8章 医薬品-医療機器コンビネーション製品市場の定性分析

第9章 結論

  • 現在の主要セグメント

付録

図表リスト

目次
Product Code: PHA0230

The global drug-device combination market was valued at $137bn in 2016 and is projected to grow at a CAGR of 6.2% in the first half of the forecast period. In 2016, the market is dominated by the Transmucosal submarket which held 21% share of the drug-device combination market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 151 page report you will receive 124 charts - all unavailable elsewhere.

The 151-page report provides clear detailed insight into the global drug-device combination market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Drug-Device Combination Market forecasts from 2017-2027
  • Revenue forecast for the drug-device combination market by End-Users:
    • Hospitals & clinics
    • Emergency service centers
    • Ambulatory surgical centers
    • Home care settings

Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World

  • Revenue forecast for the drug-device combination market by Products:
    • Drug eluting stents
    • Photosensitizers
    • Orthopaedic products
    • Infusion pumps
    • Wound care products
    • Transmucosal products
    • Transdermal patches
    • Others

Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World

  • This report provides individual revenue forecasts from 2017-2027 for these regional and national markets:
    • North America: The U.S and Rest of North America
    • Europe: France, Germany, Italy, U.K, Spain, Russia and Rest of Europe
    • Asia-Pacific: China, India, Japan, and Rest of Asia-Pacific countries
    • Rest of the world (RoW) : Latin America, and Middle East and African countries

image1

Each regional market is further divided by end-users and products

  • This report discusses the leading companies in the global drug-device combination market:
    • Medtronic
    • Boston Scientific Corporation
    • Stryker Corporation
    • Ethicon Inc
    • C.R. Bard Inc.
    • Medline Industries Inc.
    • Mylan Inc.
    • Terumo Corporation
    • Pinnacle Biologics Inc.
    • W. L. Gore & Associates, Inc.
  • This report discusses the drivers, restraints as well as porter's five forces analysis of the global drug-device combination market

Visiongain's study is intended for anyone requiring commercial analyses for the global drug-device combination market. You find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Global Drug-Device Combination Market Overview
  • 1.2 Why You Should Read This Report
  • 1.3 Key Questions Answered by This Analytical Report
  • 1.4 Who is This Report For?
  • 1.5 Methodology
  • 1.6 Frequently Asked Questions (FAQ)
  • 1.7 Associated Visiongain Reports
  • 1.8 About Visiongain

2. Drug-Device Combination Market Definition

  • 2.1 What are Drug-Device Combination Products?
  • 2.2 Types of Drug-Device Combination Products
    • 2.2.1 Drug Eluting Stents
    • 2.2.2 Photosensitizers
    • 2.2.3 Orthopedic Products
    • 2.2.4 Infusion Pumps
    • 2.2.5 Wound Care Products
    • 2.2.6 Transmucosal Products
    • 2.2.7 Transdermal Products
  • 2.3 Drug-Devices Combination Market Structure
  • 2.4 Classification of Drug-Devices Combination Market

3. Drug-Device Combination Market: Global Market by End-Users 2017-2027

  • 3.1 Hospitals & Clinics Submarket Forecast & Analysis 2017-2027
  • 3.2 Emergency Service Centers Submarket Forecast & Analysis 2017-2027
  • 3.3 Ambulatory Surgical Centers Submarket Forecast & Analysis 2017-2027
  • 3.4 Home Care Settings Submarket Forecast & Analysis 2017-2027

4. Drug-Device Combination: Global Market by Products 2017-2027

  • 4.1 Drug Eluting Stents Submarket Forecast & Analysis 2017-2027
  • 4.2 Photosensitizers Submarket Forecast & Analysis 2017-2027
  • 4.3 Orthopedic Products Submarket Forecast & Analysis 2017-2027
  • 4.4 Infusion Pumps Submarket Forecast & Analysis 2017-2027
  • 4.5 Wound Care Products Submarket Forecast & Analysis 2017-2027
  • 4.6 Transmucosal Products Submarket Forecast & Analysis 2017-2027
  • 4.7 Transdermal Products Submarket Forecast & Analysis 2017-2027
  • 4.8 Other Combination Products Submarket Forecast & Analysis 2017-2027

5. Regional Drug-Device Combination Market Forecasts 2017-2027

  • 5.1 Regional Drug-Device Combination Market Forecasts 2017-2027
  • 5.2 North American Drug-Devices Combination Market Forecasts 2017-2027
    • 5.2.1 U.S. Drug-Devices Combination Market Forecasts 2017-2027
    • 5.2.2 Rest of North America Drug-Device Combination Market Forecasts 2017-2027
  • 5.3 North American Drug-Device Combination Market Forecasts by Products 2017-2027
  • 5.4 North American Drug-Device Combination Market Forecasts by End-Users 2017-2027
  • 5.5 Europe Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.1 France Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.2 Germany Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.3 U.K. Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.4 Spain Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.5 Italy Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.6 Russia Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.7 Rest of Europe Drug-Device Combination Market Forecasts 2017-2027
  • 5.6 European Drug-Device Combination Market Forecasts by Products 2017-2027
  • 5.7 European Drug-Device Combination Market Forecasts by End-Users 2017-2027
  • 5.8 Asia-Pacific Drug-Device Combination Market Forecasts 2017-2027
    • 5.8.1 China Drug-Device Combination Market Forecasts 2017-2027
    • 5.8.2 India Drug-Device Combination Market Forecasts 2017-2027
    • 5.8.3 Japan Drug-Device Combination Market Forecasts 2017-2027
    • 5.8.4 Rest of Asia-Pacific (APAC) Drug-Device Combination Market Forecasts 2017-2027
  • 5.9 Asia-Pacific Drug-Device Combination Market Forecasts by Products 2017-2027
  • 5.10 Asia-Pacific Drug-Device Combination Market Forecasts by End-Users 2017-2027
  • 5.11 Rest of the World (RoW) Drug-Device Combination Market Forecasts 2017-2027
    • 5.11.1 Latin America Drug-Device Combination Market Forecasts 2017-2027
    • 5.11.2 Middle East and Africa Drug-Device Combination Market Forecasts 2017-2027
  • 5.12 Rest of the World (RoW) Drug-Device Combination Market Forecasts by Products 2017-2027
  • 5.13 Rest of the World (RoW) Drug-Device Combination Market Forecasts by End-Users 2017-2027

6. Drivers & Restraints

  • 6.1 Drivers and Restraints 2017-2027
  • 6.2 Drivers
    • 6.2.1 Increasing Initiatives by Government and NGO in Support of Drug Delivery Implants
    • 6.2.2 Rising popularity of minimally invasive surgeries
    • 6.2.3 Increasing Prevalence of Chronic Disorders
    • 6.2.4 Technological Innovations and Advancements
  • 6.3 Restraints
    • 6.3.1 Recall of Combination Products Due to Adverse Effects
    • 6.3.2 High Cost of Combination Products
    • 6.3.3 Regulatory and Technical Challenges Pertaining to Combination Products

7. Leading Companies in the Drug-Devices Combination Market

  • 7.1 Medtronic
    • 7.1.1 Medtronic Business Overview
    • 7.1.2 Medtronic Financial Overview
    • 7.1.3 Medtronic Product Portfolio
    • 7.1.4 Medtronic Corporate Strategy
  • 7.2 Boston Scientific Corporation
    • 7.2.1 Boston Scientific Corporation Business Overview
    • 7.2.2 Boston Scientific Corporation Financial Overview
    • 7.2.3 Boston Scientific Corporation Corporate Strategy
    • 7.2.4 Boston Scientific Corporation Product Portfolio
  • 7.3 Stryker Corporation
    • 7.3.1 Stryker Corporation Business Overview
    • 7.3.2 Stryker Corporation Financial Overview
    • 7.3.3 Stryker Corporation Product Portfolio
    • 7.3.4 Stryker Corporation Corporate Strategy
  • 7.4 Ethicon Inc.
    • 7.4.1 Ethicon Inc. Business Overview
    • 7.4.2 Ethicon Inc. Financial Overview
    • 7.4.3 Ethicon Inc. Corporate Strategy
    • 7.4.4 Ethicon Inc. Product Portfolio
  • 7.5 C. R. Bard Inc.
    • 7.5.1 C. R. Bard Inc. Business Overview
    • 7.5.2 C. R. Bard Inc. Financial Overview
    • 7.5.3 C.R. Bard Inc. Corporate Strategy
    • 7.5.4 C.R. Bard Inc. Product Portfolio
  • 7.6 Medline Industries Inc.
    • 7.6.1 Medline Industries Inc. Business Overview
    • 7.6.2 Medline Industries Inc. Financial Overview
    • 7.6.3 Medline Industries Inc. Corporate Strategy
  • 7.7 Mylan Inc.
    • 7.7.1 Mylan Inc. Business Overview
    • 7.7.2 Mylan Inc. Financial Overview
    • 7.7.3 Mylan Inc. Corporate Strategy
    • 7.7.4 Mylan Inc. Product Portfolio
  • 7.8 Terumo Corporation
    • 7.8.1 Terumo Corporation Business Overview
    • 7.8.2 Terumo Corporation Financial Overview
    • 7.8.3 Terumo Corporation Corporate Strategy
    • 7.8.4 Terumo Corporation Product Portfolio
  • 7.9 Pinnacle Biologics Inc.
    • 7.9.1 Pinnacle Biologics Inc. Business Overview
    • 7.9.2 Pinnacle Biologics Inc. Financial Overview
    • 7.9.3 Pinnacle Biologics Corporate Strategy
    • 7.9.4 Pinnacle Biologics Product Portfolio
  • 7.10 W.L. Gore & Associates Inc.
    • 7.10.1 W.L. Gore & Associates Inc. Business Overview
    • 7.10.2 W.L. Gore Associates & Inc. Financial Overview
    • 7.10.3 W.L. Gore Associates & Inc. Corporate Strategy
    • 7.10.4 W.L. Gore Associates & Inc. Product Portfolio

8. Qualitative Analysis of the Drug-Device Combination Market

  • 8.1 Porter's Five Forces Analysis of the Drug-Device Combination Market
  • 8.2 Rivalry among Competitors [High]
  • 8.3 Threat of New Entrants [Medium]
  • 8.4 Power of Suppliers [Low]
  • 8.5 Power of Buyers [Medium]
  • 8.6 Threat of Substitutes [Medium]

9. Conclusions

  • 9.1 Current Leading Drug-Device Combination Market Segments
    • 9.1.1 Leading Drug-Device Combination Products Companies
    • 9.1.2 Leading Regional Markets
    • 9.1.3 Emerging Drug-Device Combination Products Markets

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 2.1 Global Drug-Devices Combination Market Segmentation Overview, 2017
  • Figure 3.1 Global Drug-Device Combination Market by End-Users, 2016, (% Share)
  • Figure 3.2 Drug-Device Combination Submarkets, by End-Users, Forecast ($bn) 2016-2027
  • Figure 3.3 Hospital and Clinics Market Forecasts, by % AGR 2017-2027
  • Figure 3.4 Global Hospitals & Clinics Market by Region, 2016-2027
  • Figure 3.5 Global Hospitals & Clinics Market Share, by Region, (% Share) 2016-2027
  • Figure 3.6 Emergency Service Centers Submarkets Forecasts, by % AGR 2017-2027
  • Figure 3.7 Global Emergency Service Centers Market by Region, 2016-2027
  • Figure 3.8 Global Emergency Service Centers Market Share, by Region, (% Share) 2016-2027
  • Figure 3.9 Ambulatory Surgical Centers Submarkets Forecasts, by % AGR 2017-2027
  • Figure 3.10 Global Physician Offices Market by Region, 2016-2027
  • Figure 3.11 Global Physician Offices Market Share, by Region, (% Share) 2016-2027
  • Figure 3.12 Home Care Settings Submarkets Forecasts, by % AGR 2017-2027
  • Figure 3.13 Global Home Care Settings Market by Region, 2016-2027
  • Figure 3.14 Global Home Care Settings Market Share, by Region, (% Share) 2016-2027
  • Figure 4.1 Global Drug-Device Combination Market by Products, 2016, (% Share)
  • Figure 4.2 Drug-Device Combination Submarkets, by Products Type, Forecast ($bn) 2016-2027
  • Figure 4.3 Drug Eluting Stent Market Forecasts, by % AGR 2017-2027
  • Figure 4.4 Global Drug Eluting Stent Market by Region, 2016-2027
  • Figure 4.5 Global Drug Eluting Stent Market Share, by Region, (% Share) 2016-2027
  • Figure 4.6 Photosensitizers Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.7 Global Photosensitizers Market by Region, 2016-2027
  • Figure 4.8 Global Photosensitizers Market Share, by Region, (% Share) 2016-2027
  • Figure 4.9 Orthopedic Products Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.10 Global Orthopedic Products Market by Region, 2016-2027
  • Figure 4.11 Global Orthopedic Products Market Share, by Region, (% Share) 2016-2027
  • Figure 4.12 Infusion Pumps Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.13 Global Infusion Pumps Market by Region, 2016-2027
  • Figure 4.14 Global Infusion Pumps Market Share, by Region, (% Share) 2016-2027
  • Figure 4.15 Wound Care Products Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.16 Global Wound Care Products Market by Region, 2016-2027
  • Figure 4.17 Global Wound Care Products Market Share, by Region, (% Share) 2016-2027
  • Figure 4.18 Transmucosal Products Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.19 Global Transmucosal Products Market by Region, 2016-2027
  • Figure 4.20 Global Transmucosal Products Market Share, by Region, (% Share) 2016-2027
  • Figure 4.21 Transdermal Products Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.22 Global Transdermal Products Market by Region, 2016-2027
  • Figure 4.23 Global Transdermal Products Market Share, by Region, (% Share) 2016-2027
  • Figure 4.24 Other Combination Products Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.25 Global Other Combination Products Market by Region, 2016-2027
  • Figure 4.26 Global Other Combination Products Market Share, by Region, (% Share) 2016-2027
  • Figure 5.1 Regional Drug-Device Combination Market Forecasts ($bn), 2017-2027
  • Figure 5.2 Regional Drug-Device Combination Market Share (%), 2016
  • Figure 5.3 North American Drug-Devices Combination Market Share Analysis, by Country ($bn, AGR%), 2016
  • Figure 5.4 U.S. Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.5 Rest of North America Pharma Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.6 North American Drug-Device Combination Market Revenue Analysis, by Product ($bn, AGR%), 2016-2027
  • Figure 5.7 North American Cancer Drug-Device Combination Market Revenue Analysis, by End-Users ($bn, AGR%), 2016-2027
  • Figure 5.8 European Pharma Clinical Trial Services Market Share Analysis, by Country ($bn, AGR%), 2016
  • Figure 5.9 France Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.10 Germany Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.11 U.K. Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.12 Spain Pharma Clinical Trial Services Market Forecasts ($bn), 2016-2027
  • Figure 5.13 Italy Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.14 Russia Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.15 Rest of Europe Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.16 European Drug-Device Combination Market Revenue Analysis, by Product ($bn, AGR%), 2016-2027
  • Figure 5.17 European Drug-Device Combination Market Revenue Analysis, by End-Users ($bn, AGR%), 2016-2027
  • Figure 5.18 Asia-Pacific Drug-Device Combination Market Share Analysis, by Country ($bn, AGR%), 2016
  • Figure 5.19 China Drug-Device Market Forecasts ($bn), 2016-2027
  • Figure 5.20 India Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.21 Japan Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.22 Rest of Asia-Pacific (APAC) Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.23 Asia-Pacific Drug-Device Combination Market Revenue Analysis, by Products ($bn, AGR%), 2016-2027
  • Figure 5.24 Asia-Pacific Drug-Device Combination Market Revenue Analysis, by End-Users ($bn, AGR%), 2016-2027
  • Figure 5.25 Rest of the World (RoW) Drug-Device Combination Market Share Analysis, by Country ($bn, AGR%), 2016-2027
  • Figure 5.26 Latin America Drug-Device Combination Market Forecasts ($mn), 2016-2027
  • Figure 5.27 Middle East and Africa Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.28 RoW Drug-Devices Combination Market Revenue Analysis, by Products ($bn, AGR%), 2016-2027
  • Figure 5.29 RoW Drug-Device Combination Market Revenue Analysis, by End-Users ($bn, AGR%), 2016-2027
  • Figure 6.1 Market: Drivers and Restraints, 2017-2027
  • Figure 7.1 Medtronic 2016 Annual Revenue by Business Segments
  • Figure 7.2 Medtronic Annual Revenue 2012- 2016 ($mn)
  • Figure 7.3 Boston Scientific Corporation 2016 Annual Revenue by Business Segments
  • Figure 7.4 Boston Scientific Corporation Annual Revenue 2012- 2016 ($mn)
  • Figure 7.5 Stryker Corporation 2016 Annual Revenue by Business Segments
  • Figure 7.6 Stryker Corporation Annual Revenue 2012- 2016 ($mn)
  • Figure 7.7 Johnson & Johnson 2016 Annual Revenue by Business Segments
  • Figure 7.8 Johnson & Johnson Annual Revenue 2012- 2016 ($mn)
  • Figure 7.9 C.R. Bard Inc. 2016 Annual Revenue by Business Segments
  • Figure 7.10 C. R. Bard Inc. Annual Revenue 2012- 2016 ($mn)
  • Figure 7.11 Mylan Inc. 2016 Annual Revenue by Business Segments
  • Figure 7.12 Mylan Inc. Annual Revenue 2012- 2016 ($mn)
  • Figure 7.13 Terumo Corporation 2016 Annual Revenue by Business Segments
  • Figure 7.14 Terumo Corporation Annual Revenue 2012- 2016 ($mn)
  • Figure 8.1 Porter's Five Forces Analysis of the Drug-Device Combination Market, 2017-2027

List of Tables

  • Table 3.1 Drug-Device Combination Products Submarkets, by End-Users Forecast ($bn, CAGR%)
  • Table 3.2 Hospitals/Clinical Laboratories Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 3.3 Emergency Service Centers Markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 3.4 Ambulatory Surgical Centers Markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 3.5 Home Care Settings markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.1 Drug-Device Combination Submarkets, by Products Type Forecast ($bn, CAGR%)
  • Table 4.2 Drug Eluting Stent Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.3 Photosensitizers Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.4 Orthopedic Products markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.5 Infusion Pumps Markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.6 Wound Care Products Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.7 Transmucosal Products Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.8 Transdermal Products Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.9 Other Combination Products Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 5.1 Regional Drug-Devices Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.2 U.S. Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.3 Rest of North America Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.4 North American Drug-Device Combination Market Forecasts, by Products Type ($bn, AGR% CAGR%) 2016-2027
  • Table 5.5 North American Drug-Device Combination Market Forecasts, by End-Users ($bn, AGR% CAGR%) 2016-2027
  • Table 5.6 France Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.7 Germany Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.8 U.K. Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.9 Spain Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.10 Italy Pharma Clinical Trial Services Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.11 Russia Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.12 Rest of Europe Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.13 European Drug-Device Combination Market Forecasts, by Products ($bn, AGR% CAGR%) 2016-2027
  • Table 5.14 European Drug-Device Combination Market Forecasts, by End-Users ($bn, AGR% CAGR%) 2016-2027
  • Table 5.15 China Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.16 India Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.17 Japan Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.18 Rest of Asia-Pacific (APAC) Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.19 Asia-Pacific Drug-Device Combination Market Forecasts, by Products ($bn, AGR% CAGR%) 2016-2027
  • Table 5.20 Asia-Pacific Drug-Device Combination Market Forecasts, by End-Users ($bn, AGR% CAGR%) 2016-2027
  • Table 5.21 Latin America Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.22 Middle East and Africa Pharma Clinical Trial Services Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.23 RoW Pharma Drug-Device Combination Market Forecasts, by Products ($bn, AGR% CAGR%) 2016-2027
  • Table 5.24 RoW Drug-Device Combination Market Forecasts, by Products ($bn, AGR% CAGR%) 2016-2027

Companies Listed

  • Bayer
  • Baxter Healthcare
  • Boehringer Ingelheim
  • Boston Scientific Corporation
  • C.R. Bard Inc.
  • CeloNova Biosciences
  • Center for Biologics Evaluation and Research (CBER)
  • Center for Devices and Radiological Health (CDRH)
  • Center for Drug Evaluation and Research (CDER)
  • Ethicon Inc
  • Johnson & Johnson Co.
  • Meda
  • Medline Industries Inc.
  • Medtronic
  • Menarini Group
  • Merck KGaA
  • Mylan Inc.
  • National Institute of Health and Care Excellence (NICE)
  • NeuWave Medical, Inc.
  • Orion Corporation
  • PhysioControl International, Inc.
  • Pinnacle Biologics Inc.
  • Sage Products, LLC
  • Stryker Corporation
  • Synergetics
  • Terumo Corporation
  • Unites States Food and Drug Administration (FDA)
  • ViaCyte, Inc.
  • W. L. Gore & Associates, Inc.
  • World Health Organization (WHO)
Back to Top